Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Announcements
for
Ajanta Pharma Ltd.
15 Apr
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
15 Apr
Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Period Ended 31St March 2024.
12 Apr
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
11 Apr
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
04 Apr
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
30 Mar
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
29 Mar
Closure of Trading Window
22 Mar
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
22 Mar
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
22 Mar
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
View announcements
for all companies
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist